Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1285698

[Cl-].[Cl-].[Cl-].[Na+].[Na+].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119409781-A Purification method of Fim2/3 pilin without pertussis component antigen residues 北京生物制品研究所有限责任公司 2025-02-11 CN claimed
CN-118844836-A Long-acting disinfection and sterilization wet (towel) paper 孙国明 2024-10-29 CN claimed
CN-117883371-A Gatifloxacin eye drops and preparation method thereof 广州仁恒制药有限公司 2024-04-16 CN claimed
US-11918655-B2 Intranasal epinephrine formulations and methods for the treatment of disease AEGIS THERAPEUTICS, LLC (US) 2024-03-05 US claimed
US-20240024485-A1 INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE NEF ROYALTY SUB LLC 2024-01-25 US claimed
CN-116349679-A Composite disinfection and sterilization method 孙国明 2023-06-30 CN claimed
CN-115819115-A Preparation method of ceramic glaze 康姆罗拉有限公司 2023-03-21 CN claimed
CN-110898002-B Bone peptide injection and preparation method and application thereof 湖北威仕生物药业股份有限公司 2022-05-10 CN claimed
CN-113751495-B Soil remediation agent for chlorophenol pollution 安徽大学 2022-04-22 CN claimed
JP-60253869-A None JP disclosed
CN-117126138-B Compound for degrading target protein in ubiquitin-proteasome system, and preparation method and application thereof 深圳湾实验室坪山生物医药研发转化中心 2026-05-22 CN disclosed
US-20260132413-A1 AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME WISCONSIN ALUMNI RES FOUNDATION (US) 2026-05-14 US disclosed
EP-3010517-B1 IMMUNOTHERAPY COMPOSITION AND USE THEREOF ONDEK PTY LTD (AU) 2026-04-08 EP disclosed
EP-3996680-B1 STABLE FORMULATIONS OF RECOMBINANT PROTEINS UNICHEM LAB LTD (IN) 2026-03-11 EP disclosed
WO-1998030575-A1 BIOCONJUGATION OF MACROMOLECULES PROLIGO LLC (US) 1998-07-16 WO disclosed
WO-1998014690-A2 SETTING COMPOSITION FOR WELL OPERATIONS SOFITECH N.V. (BE) 1998-04-09 WO disclosed
US-5733787-A COPPER IONS, HYDROPEROXIDE, CHELATING AGENT BAYER CORPORATION (US) 1998-03-31 US disclosed
US-4822733-A MONITORING TWO PHOTOPHORE-LABELLED PROBES, EMISSION LIVES, LUMINESCENCE AMOCO CORPORATION (US) 1989-04-18 US disclosed
JP-S60253869-A REAGENT FOR MESURING ANTI-ARTIFICIAL NUCLEUS ANTIGEN ANTIBODY MITSUI PHARMACEUT INC 1985-12-14 JP disclosed
US-4138443-A USING AN ACTIVATED ALUMINA SUPPORTED RHODIUM CATALYST ALSO CONTAINING ZINC, COPPER, NICKEL, COBALT AND/OR IRON SOCIETE FRANCAISE DES PRODUITS POUR CATALYSE "PROCATALYSE" (FR) 1979-02-06 US disclosed